Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study
KA Swedish, SH Factor… - Clinical infectious …, 2012 - academic.oup.com
Background. Most squamous cell anal cancers and precancerous lesions are attributed to
human papillomavirus (HPV) infection. By preventing HPV infection, quadrivalent HPV …
human papillomavirus (HPV) infection. By preventing HPV infection, quadrivalent HPV …
[HTML][HTML] HPV vaccine against anal HPV infection and anal intraepithelial neoplasia
JM Palefsky, AR Giuliano, S Goldstone… - … England Journal of …, 2011 - Mass Medical Soc
Background The rate of anal cancer is increasing among both women and men, particularly
men who have sex with men. Caused by infection with human papillomavirus (HPV) …
men who have sex with men. Caused by infection with human papillomavirus (HPV) …
Long-term outcomes of adding HPV vaccine to the anal intraepithelial neoplasia treatment regimen in HIV-positive men who have sex with men
Background. Recent evidence shows that quadrivalent human papillomavirus (qHPV)
vaccination in men who have sex with men (MSM) who have a history of high-grade anal …
vaccination in men who have sex with men (MSM) who have a history of high-grade anal …
Prophylactic HPV vaccination and anal cancer
EA Stier, NL Chigurupati, L Fung - Human vaccines & …, 2016 - Taylor & Francis
The incidence of anal cancer is increasing. High risk populations include HIV-positive men
who have sex with men (MSM), HIV-negative MSM, HIV-positive women and heterosexual …
who have sex with men (MSM), HIV-negative MSM, HIV-positive women and heterosexual …
High prevalence of anal high-grade squamous intraepithelial lesions, and prevention through human papillomavirus vaccination, in young men who have sex with …
JM Palefsky, SY Lensing, M Belzer, J Lee… - Clinical Infectious …, 2021 - academic.oup.com
Background Men who have sex with men (MSM) are at high risk for human papillomavirus
(HPV)–related anal cancer. Little is known about the prevalence of low-grade squamous …
(HPV)–related anal cancer. Little is known about the prevalence of low-grade squamous …
Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high …
AA Deshmukh, EY Chiao, P Das, SB Cantor - Vaccine, 2014 - Elsevier
We examined the long-term clinical and economic benefits of quadrivalent human
papillomavirus (qHPV) vaccine as a secondary/adjunct prevention strategy in the prevention …
papillomavirus (qHPV) vaccine as a secondary/adjunct prevention strategy in the prevention …
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men
T Wilkin, JY Lee, SY Lensing, EA Stier… - The Journal of …, 2010 - academic.oup.com
Background. Human immunodeficiency virus type 1 (HIV-1)-infected men are at increased
risk for anal cancer. Human papillomavirus (HPV) vaccination may prevent anal cancer …
risk for anal cancer. Human papillomavirus (HPV) vaccination may prevent anal cancer …
Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction
M Steinau, ER Unger, BY Hernandez… - Journal of lower …, 2013 - journals.lww.com
Objective This study aimed to conduct a representative survey of human papillomavirus
(HPV) prevalence and its genotype distribution in invasive anal cancer specimens in the …
(HPV) prevalence and its genotype distribution in invasive anal cancer specimens in the …
The epidemiology of anal cancer
AE Grulich, IM Poynten, DA Machalek, F Jin… - Sexual …, 2012 - CSIRO Publishing
Anal cancer comprises malignancies of the anal canal principally of two morphologic
variants: squamous cell carcinoma (SCC) and adenocarcinoma. In most settings, SCC …
variants: squamous cell carcinoma (SCC) and adenocarcinoma. In most settings, SCC …
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males-Advisory Committee on Immunization Practices (ACIP), 2011.
Centers for Disease Control and … - MMWR: Morbidity & …, 2011 - search.ebscohost.com
Abstract On October 25, 2011, the Advisory Committee on Immunization Practices (ACIP)
recommended routine use of quadrivalent human papillomavirus (HPV) vaccine (HPV4; …
recommended routine use of quadrivalent human papillomavirus (HPV) vaccine (HPV4; …